ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings Inc (CERO)

0.2488
-0.0093
(-3.60%)
Cerrado 20 Noviembre 3:00PM
0.2554
0.0066
( 2.65% )
Pre Mercado: 6:56AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
0.2554
Postura de Compra
0.25
Postura de Venta
0.2559
Volume Operado de la Acción
159,411
0.00 Rango del Día 0.00
0.0636 Rango de 52 semanas 12.38
Precio Anterior
0.2488
Precio de Apertura
-
Última hora de negociación
06:56:12
Volumen promedio (3 m)
68,632,299
Volumen financiero
-
Precio Promedio Ponderado
-

CERO Últimas noticias

CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia

SOUTH SAN FRANCISCO, Calif, Nov. 15, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next...

CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity

Data presented as part of a poster at the SITC 2024 Conference SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an...

CERo Therapeutics, Inc. Provides Corporate Update

Company announces submission of IND Clinical Hold Complete Response Letter SOUTH SAN FRANCISCO, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...

CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer

SOUTH SAN FRANCISCO, Calif, Oct. 02, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation...

CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236

Company requests Type A Meeting with U.S. Food and Drug Administration regarding clinical hold for CER-1236; announces key management changes SOUTH SAN FRANCISCO, Calif., Sept. 25, 2024 (GLOBE...

CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024

Company anticipates initial human trials to focus on AML upon IND clearance SOUTH SAN FRANCISCO, Calif., July 08, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...

CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236

Company anticipates near term filing of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq:...

CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236

Company continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 06, 2024 (GLOBE NEWSWIRE) --  CERo...

CERo Therapeutics, Inc. Provides Corporate Update for Shareholders

SOUTH SAN FRANCISCO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq:CERO) (“CERo”) an innovative immunotherapy company seeking to advance the next generation...

CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes

SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) (“CERo”) an innovative immunotherapy company seeking to advance the next...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.047722.96581608090.20770.44770.182533681040.2818884CS
40.1742214.5320197040.08120.44770.06361779751080.24107635CS
120.125496.46153846150.130.44770.0636686322990.2245613CS
26-0.7846-75.44230769231.041.080.0636344167480.22526693CS
52-4.9946-95.13523809525.2512.380.0636230044900.26925908CS
156-4.9946-95.13523809525.2512.380.0636230044900.26925908CS
260-4.9946-95.13523809525.2512.380.0636230044900.26925908CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CDTConduit Pharmaceuticals Inc
US$ 0.1976
(114.08%)
38.12M
WORXSCWorx Corporation
US$ 1.93
(96.94%)
21.95M
PETWag Group Company
US$ 0.307
(46.12%)
21.32M
AKTSAkoustis Technologies Inc
US$ 0.1271
(45.92%)
87.28M
ESGROEnstar Group Ltd
US$ 28.00
(40.92%)
29
WSBFWaterstone Financial Inc
US$ 9.00
(-40.98%)
6
TRSTriMas Corporation
US$ 15.62
(-40.79%)
4
BCAXBicara Therapeutics Inc
US$ 11.00
(-40.15%)
316
PYXSPyxis Oncology Inc
US$ 2.40
(-37.17%)
742.33k
XNCRXencor Inc
US$ 15.11
(-36.30%)
7
AKTSAkoustis Technologies Inc
US$ 0.1271
(45.92%)
87.28M
CDTConduit Pharmaceuticals Inc
US$ 0.1976
(114.08%)
38.12M
WORXSCWorx Corporation
US$ 1.93
(96.94%)
21.95M
PETWag Group Company
US$ 0.307
(46.12%)
21.32M
XTKGX3 Holdings Company Ltd
US$ 0.0809
(-10.11%)
11.25M

CERO Discussion

Ver más
The Night Stalker The Night Stalker 19 horas hace
NICE
👍️ 1
nothing-but-patience nothing-but-patience 2 días hace
Anyone buying warrants here? CEROW
👍️0
boston127 boston127 5 días hace
2 posts in 7 years.

Not taking you too seriously. Hey, life is good when we are making $$. Please fell free to PM me all tips, as I always do my DD on any recommendation made in good faith.
👍️0
glenn1919 glenn1919 5 días hace
CERO.............................https://stockcharts.com/h-sc/ui?s=CERO&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 6 días hace
Your very welcome...Happy you made great trades off my call...🥳
👍️0
Godric Godric 6 días hace
I for one can vouch for Georgie, solid chart reading and sound advice. I sold previously because he posted about the R/S etc. which saved me quite a bit of money. I also bought in on the low after the news as well. Can confirm I bought in at .23 per share. Sold it staggered all the way up to .40. Wasn't sure how high we would get. Wins a win though. 

Georgie you're awesome. Thanks for doing what you do 🙏
👍️0
Timing101 Timing101 6 días hace
$CERO This could move , consolidating now , was just in the $1.00 + range less than six months ago. Close Green today and then clear that .37 range off it goes.
News strong out today . FDA Clearance to move forward. https://finance.yahoo.com/news/cero-therapeutics-inc-receives-fda-134500755.html
👍️0
georgie18 georgie18 6 días hace
Just because your not interested doesn't matter to me...There are many of my followers that are interested...I am not bragging... just posting what I did because people ask me too...

If you paid attention I posted this at .08 range and because of the offering that CERO filed for millions of shares and the announcement of a REVERSE SPLIT ...I sold my shares for a nice profit in the .30 range...

This morning I bought back in PRE MARKET at the .21 range and sold in the 38/39 range for a flip on this morning NEWS which posted at 8:45...and I posted that so my followers would know that I am not holding...

I know all about the NEWS ...and I know all about the dilution coming because of the offering...and also the REVERSE SPLIT that's coming...and for those reasons I am not holding any shares...

I don't give a rats ass if you believe me or not...but for my followers that trust my trades and have made huge amounts of profit on my calls...my posts are helpful...

You have a great day...🥳
👍️ 1
georgie18 georgie18 6 días hace
News hit CERO at 8:45 in pre market...It was .18 range at that time where it closed the day before and proceeded to run into the .30s...Before you make accusations check the facts...🥳
👍️0
boston127 boston127 6 días hace
The low of the day was .26.

Including premarket. It opened at 33. But, you somehow bought at 21? Yeah, right!
👍️0
boston127 boston127 6 días hace
I'm confused. Why post your one day trades?

I have no interest. I'm here for the long term. The company may have a solution to ovarian cancer, and you are bragging about your buys at the low of the day, and your sales at the high of one day? Not interested and do not believe you.
👍️0
glenn1919 glenn1919 6 días hace
CERO.......................https://stockcharts.com/h-sc/ui?s=CERO&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 6 días hace
CERO...All out at .38/39...from .21s this morning...🥳

georgie18

Member Level
Re: georgie18 post# 664663

Friday, November 15, 2024 8:47:58 AM

Post#
665102
of 665112
CERO...21s clearing here...Back in on News for a flip...🥳
👍️0
georgie18 georgie18 6 días hace
CERO...21s clearing here...Back in on News for a flip...🥳
👍️0
boston127 boston127 7 días hace
Any progress against the Silent Killer

is worth billions. Ovarian cancer is horrible, as healthy patients do not find out about it until it is too late. Ovarian cancer develops when abnormal cells within the ovaries begin to grow and multiply uncontrollably, forming a tumor. There are very vague symptoms in early stages, making detection difficult. I'm here for the long term.
👍️0
boston127 boston127 7 días hace
The bank will be made here soon.

We have just begun to run. No snake oil company here. Looking for a major run within the next 90 days.
👍️0
Crappie1979 Crappie1979 1 semana hace
yes it is
👍️0
boston127 boston127 1 semana hace
Nice comeback today.

Wish I bought today when it was low.
👍️0
1-1 is 4 1-1 is 4 1 semana hace
The President-elect has said he wants Robert F. Kennedy Jr. to be part of his health care team, and psychedelics are at the top of a list of things, including raw milk, chelating compounds and sunshine, Kennedy alleges the Food and Drug Administration is keeping away from Americans. By ERIN SCHUMAKER, DANIEL PAYNE, RUTH READER and CARMEN PAUN 11/11/2024 02:00 PM EST
👍️0
georgie18 georgie18 1 semana hace
Maybe...🥳
👍️0
zendeli1 zendeli1 1 semana hace
restart soon
👍️0
georgie18 georgie18 1 semana hace
CERO...Just saw this...🥳...so out for now with a nice profit...https://www.otcmarkets.com/filing/html?id=17958534&guid=lzY-kaseQ9GaJth
👍️0
Invest-in-America Invest-in-America 1 semana hace
CERO: CONGRATS, Dude!!! (THAT's how ya fluck with these Snake-Oil-Pharma firms!!! Ya make bank off of THEM, before they make bank off of YOU!!!)
👍️0
Invest-in-America Invest-in-America 1 semana hace
CERO: This (Homeopathy) snake oil stock will Close RED today!!! (Mark it!!!)
👍️0
Invest-in-America Invest-in-America 1 semana hace
NO they are NOT, Sir!!! And indeed, THAT is why there has been NO FRICKIN' CURE for ANY form of Cancer on this stupid Planet for circa 7,000-years of so-called "CIVILIZATION"!!! (The ONLY way Cancers can be cured is vis-a-vis RE-EDITING the extant GENOMES of patients' Cancer cells THEMSELVES!!! And NOT by attempting to KILL those defective Cancer cells!!!)
👍️0
Invest-in-America Invest-in-America 1 semana hace
CERO: One last warning --- take you profits and RUN!!! (LEAD METAL --- of any fashion ---has NO place in the Human BODY, nor in PAINT, nor in the ENVIRONMENT, & will soon be forbidden even in lead FISHING weights!!!)
👍️0
1-1 is 4 1-1 is 4 1 semana hace
Current chemotherapy ingredients include mustard gas, a known carcinogen. Cancer causing chemicals are used to treat cancer.
👍️0
hondaboost hondaboost 1 semana hace
CERO,great run. Bought tons at $0.08.
👍️0
georgie18 georgie18 1 semana hace
CERO...33s clearing here...Next stop .80s if this volume sticks...🥳

CERO...28s clearing here...🥳

CERO...2178...Off my .08 Alert...🥳Holding and bidding the open gap...🥳

georgie18

Member Level
Re: georgie18 post# 181

Monday, November 11, 2024 2:09:32 PM

Post#
186
of 196
CERO...179...Bidding the Gap .07 to .14...🥳Alerted at .08 Range and ran to .23 range...
👍️ 1
georgie18 georgie18 1 semana hace
CERO...28s clearing here...🥳

CERO...2178...Off my .08 Alert...🥳Holding and bidding the open gap...🥳

georgie18

Member Level
Re: georgie18 post# 181

Monday, November 11, 2024 2:09:32 PM

Post#
186
of 196
CERO...179...Bidding the Gap .07 to .14...🥳Alerted at .08 Range and ran to .23 range...
👍️0
georgie18 georgie18 1 semana hace
CERO...2178...Off my .08 Alert...🥳Holding and bidding the open gap...🥳

georgie18

Member Level
Re: georgie18 post# 181

Monday, November 11, 2024 2:09:32 PM

Post#
186
of 196
CERO...179...Bidding the Gap .07 to .14...🥳Alerted at .08 Range and ran to .23 range...
👍️0
Invest-in-America Invest-in-America 1 semana hace
CERO: More by "Copilot", regarding the DIFFERENCE between CERO's (fluff-news) "Animal MODEL", vs. legitimate & substantive "Animal STUDIES" ---

"However, can such a Human Pharma research company produce an "ANIMAL MODEL" without having conducted any actual "ANIMAL STUDIES"? I.e., can said company merely be referring to their THEORETICAL concepts for FUTURE actual animal STUDIES & EXPERIMENTS, without having acutally done such studies, etc.? Yes, a pharmaceutical company can indeed refer to an "animal model" in a theoretical context without having conducted actual animal studies. They might outline the animal model they intend to use based on existing knowledge or previous research. This can include describing the species, genetic modifications, or other characteristics that make the animal suitable for studying a particular disease.However, to claim progress or make definitive statements about the efficacy or safety of a drug, actual animal studies and experiments are necessary. These studies provide the empirical data needed to move forward in the drug development process, including eventual human trials. So, while a company can theoretically discuss their planned animal models, the actual validation of those models requires conducting the animal studies. Does that help clarify things for you?"
👍️0
Invest-in-America Invest-in-America 1 semana hace
CERO: Are you, UNDER PRESSURE?????

👍️0
Invest-in-America Invest-in-America 1 semana hace
CERO: Below is Bing's "Copilot" for your EDIFICATION regarding this conspicuously-SCAMMING, stinky pinky "company" ---

"What was the name of the influential 'health care' movement of the 20th Century that advocated the consumption of tiny doses of well-known POISONS & TOXIC METALS LIKE LEAD as a cure for all manner of deadly diseases? The influential health care movement you're referring to is likely Homeopathy. Developed in the late 18th century by Samuel Hahnemann, Homeopathy is based on the principle of 'like cures like' and the use of highly diluted substances to treat various ailments. While modern Homeopathy typically uses extremely diluted substances, some historical practices involved the use of tiny doses of known poisons and toxic metals, believing that these could stimulate the body's healing processes. Homeopathy remains a controversial topic in the medical community, with debates about its efficacy and scientific basis. Do you have any specific interest in homeopathy or its history?"
👍️0
Invest-in-America Invest-in-America 1 semana hace
CERO: This CERO stinky stock --- & its LEAD-based Cancer concoction --- is now headed to a ZERO!!!!

👍️0
Invest-in-America Invest-in-America 1 semana hace
CERO: Below is WHERE this goes "AH", Bro!!!! (But they sure had great news about their TEST TUBE findings!!! Heck, "NO TOXICITY" to the TEST TUBES!!! Remember, they said "ANIMAL MODEL" --- and not, "ANIMAL STUDIES"!!!)

👍️0
Invest-in-America Invest-in-America 1 semana hace
CERO: Someone just dumped a TRUCK LOAD of this LEAD-lined snake oil firm!!!
👍️0
Invest-in-America Invest-in-America 1 semana hace
CERO: NOT even at the ANIMAL studies level yet; so don't get TOO excited!! (Nonetheless, CONGRATS to those here --- e.g., 'GEORGIE' --- who already scored big BANK off this conspicuous SNAKE OIL company!!! Sure, inject a LEAD COMPOUND into Cancer patients to 'cure' that affliction!!!)

👍️0
JUST 10-11-12 JUST 10-11-12 1 semana hace
Does cero go ah?
👍️0
MartinLutherKing MartinLutherKing 1 semana hace
Live the dream brothers
👍️0
Invest-in-America Invest-in-America 1 semana hace
CERO: Copilot ---
"What was the name of that company or person who claimed a few decades ago that MICRO-PULVERIZED-LEAD-METAL could be affixed to an immunotheraputic compond and then INJECTED into Cancer patients; and, as such, said LEAD molecutes/atoms would then affix themselves to the Cancer cells; and, lastly, the Cancer cells would be DESTROYED when said patients were bombarded with MICROWAVE RADIATION, which would HEAT-UP the Cancer cells and thereby DESTROY them.

I'm sorry, but I couldn't find any specific information about a company or person making such claims regarding micro-pulverized lead metal for cancer treatment. It's possible that this was a fringe or unverified claim that never gained widespread attention or credibility."
👍️0
georgie18 georgie18 1 semana hace
CERO...179...Bidding the Gap .07 to .14...🥳Alerted at .08 Range and ran to .23 range...
👍️0
Invest-in-America Invest-in-America 1 semana hace
CERO: Copilot ---
"What was the name of that old snake oil movement that advocated the consumption of tiny portions of lead, arsnic, & other poisonous substances as a cure for Cancer, inter alia?
You're likely thinking of the patent medicine movement that was popular in the late 19th and early 20th centuries. These "snake oil" products often contained harmful substances like lead, arsenic, mercury, and other toxic ingredients, marketed as cure-alls for various ailments, including cancer. Many of these products made outrageous claims and were not backed by scientific evidence, leading to widespread medical quackery.

It's fascinating (and a bit alarming) to look back at how far medical science has come since then. Do you have a particular interest in the history of medicine or these old remedies?"
👍️0
Money hunt Money hunt 1 semana hace
Sorry l, it reversed in your face
👍️0
Timing101 Timing101 1 semana hace
$CERO No denying there is quite the battle going on here back and forth on level 2 and the Volume is Amazing, plus not slowing down going to go past a BILLION shares traded shortly so far today.
👍️0
georgie18 georgie18 1 semana hace
Thanks...Happy you are as well...will have to follow you again...you always had very logical and profitable picks...🥳
👍️ 1
georgie18 georgie18 1 semana hace
CERO...21s clearing here off my .08 Range Alert...🥳

georgie18

Member Level
Re: georgie18 post# 165

Monday, November 11, 2024 8:28:09 AM

Post#
167
of 180
CERO...175...Off my .08 range alert...🥳

georgie18

Member Level
Re: georgie18 post# 664359

Monday, November 11, 2024 8:24:01 AM

Post#
664360
of 664360
CERO...14s clearing here off my .08 range alert...🥳

georgie18

Member Level
Re: georgie18 post# 163

Monday, November 11, 2024 8:20:29 AM

Post#
164
of 164
CERO....10s clearing here off my .08 Range Alert...🥳...Another patience play...SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces the presentation of preclinical data demonstrating the capability of its lead compound CER-1236 to kill ovarian cancer cells in preclinical models with no indications of toxicity in animal models. The data were presented in a poster at the Society for Immunology of Cancer (SITC) 2024 conference held in Houston November 6-10, 2024.

Interim CEO Chris Ehrlich commented, “We have long contended that CER-1236 has application in multiple cancer types. While we await the opportunity to introduce our compound into the clinic for AML, we continue to see other models in which there is utility and minimal-to-no toxicity. These data are of particular interest as the Company plans to apply for Orphan designation at the appropriate time in clinical development. Regardless, these data are further confirmation that our approach has enormous potential to go beyond some of the limitations of current chemotherapy approaches.”

The study, titled, “TIM-4 Expression on Ovarian Cancer Samples can be Targeted by Engineered Chimeric Engulfment Receptor T cells without Toxicity,” investigators assessed CER-1236 on the immune receptor TIM-4-L in ovarian cancer cell lines. Results demonstrated that following the introduction of CER-1236 on these cell lines, TIM-4-L increased, which then responded with the killing of the cancer cells, but with no observed toxicity to healthy cells. The study further showed CER-1236 specificity to TIM-L-4, which investigators concluded that combined with the lack of association with clinically relevant toxicity, may make the compound an attractive option for treating ovarian cancer.

georgie18

Member Level
Re: georgie18 post# 384735

Tuesday, October 29, 2024 10:18:14 AM

Post#
384978
of 385445
CERO...0817...HOD...Alerted at .0843...Looks like she wants to turn up here...🥳

georgie18

Member Level
Re: georgie18 post# 161

Wednesday, October 23, 2024 8:43:17 AM

Post#
162
of 162
CERO...884...off my .0843 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 384664

Tuesday, October 22, 2024 4:54:59 PM

Post#
384719
of 384734
CERO...Churned a lot of .08s today...🥳

georgie18

Member Level
Re: None

Tuesday, October 22, 2024 9:21:41 AM

Post#
160
of 160
CERO...0843...🥳...Bullish Piercing Line on the close last night...Scaling in with some volume hitting this morning...
👍️0
PinkPennies PinkPennies 1 semana hace
so happy to hear you are doing well .. I'm doing good also
👍️0
madras50 madras50 1 semana hace
This going to bust out or they diluting or probably just profit taking? Sounds like pretty big news
👍️0
georgie18 georgie18 1 semana hace
Nice trade and thanks...🥳
👍️0

Su Consulta Reciente

Delayed Upgrade Clock